Research discovery leads to new clinical trial for myelofibrosis patients
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis ...
Jun 20, 2019
0
3